We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, KV Pharmaceutical Agree to Consent Decree
FDA, KV Pharmaceutical Agree to Consent Decree
March 2, 2009
KV Pharmaceutical has a clearer path to resume sales after it and the FDA agreed to a consent decree that allows the company to resume production operations once its facilities are deemed compliant with current good manufacturing practices (cGMP).